SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-011355
Filing Date
2024-08-07
Accepted
2024-08-07 16:10:48
Documents
16
Period of Report
2024-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gbio-20240807x8k.htm   iXBRL 8-K 36235
2 EX-99.1 gbio-20240807xex99d1.htm EX-99.1 62418
3 GRAPHIC gbio-20240807xex99d1001.jpg GRAPHIC 6132
  Complete submission text file 0001558370-24-011355.txt   235652

Data Files

Seq Description Document Type Size
4 EX-101.SCH gbio-20240807.xsd EX-101.SCH 3993
5 EX-101.DEF gbio-20240807_def.xml EX-101.DEF 2734
6 EX-101.LAB gbio-20240807_lab.xml EX-101.LAB 13966
7 EX-101.PRE gbio-20240807_pre.xml EX-101.PRE 10832
18 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20240807x8k_htm.xml XML 4614
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39319 | Film No.: 241183837
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)